Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative versus postoperative chemotherapy for resectable colorectal liver metastases
ACTRN12610000647033Phase 3Terminated
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Start
- Oct 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin, capecitabine, fluorouracil, folinic acid and irinotecan in colorectal cancer (CRC) (2 arms), sponsored by Australasian Gastro-Intestinal Trials Group. Primary endpoint: Peri-operative morbidity. Started Oct 2011; status: terminated.
02
Drugs
oxaliplatincapecitabinefluorouracilfolinic acidirinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ACTRN12610000647033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000647033.